Indivior dives after late profit warning
26th Sep 2018 16:37
(Sharecast News) - Drug company Indivior has reinstated its full year guidance, after withdrawing it in July due to uncertainty about court challenges from rivals.
Read moreHurricane Florence sees Indivior release Sublocade presentation early
12th Sep 2018 09:56
(Sharecast News) - Indivior announced on Wednesday that, due to "adverse weather" expected from Hurricane Florence, the recently-declared state of emergency in Virginia and its likely impact on East Coast travel in the US, the company was unable to participate in Morgan Stanley's 16th Annual Global Healthcare Conference.
Read moreIndivior pays off part of term loan facility
10th Sep 2018 08:03
(Sharecast News) - Indivior has prepaid $150m of outstanding debt, it confirmed on Monday.
Read moreIndivior beats Dr Reddy's in the courts again
31st Jul 2018 08:28
(Sharecast News) - Indivior's lawyers have achieved another victory in the drug developer's ongoing US court battle, which will prevent rival Dr Reddy's Laboratories from selling its generic version of Suboxone Film.
Read moreIndivior beats Dr Reddy's in the courts again
31st Jul 2018 08:28
(Sharecast News) - Indivior's lawyers have achieved another victory in the drug developer's ongoing US court battle, which will prevent rival Dr Reddy's Laboratories from selling its generic version of Suboxone Film.
Read moreIndivior given October court date with Dr Reddy's, delays Perseris launch
30th Jul 2018 07:08
(Sharecast News) - Indivior's lawyers will be able to begin arguing the drug developer's case against Dr Reddy Laboratories in October, after the US appeals court agreed to speed up the process.
Read moreFriday broker round-up
27th Jul 2018 13:14
(Sharecast News) - William Hill: Peel Hunt upgrades to hold with a target price of 305p.
Read moreWednesday broker round-up
25th Jul 2018 13:57
(Sharecast News) - Unite Group: Numis downgrades to hold with a target price of 900p.
Read moreIndivior first half marred by ongoing Dr Reddy's litigation
25th Jul 2018 08:46
(Sharecast News) - Drug developer Indivior reported a 13% fall in first-half profits to $147m after losing market share for its main product and just $2m of sales from its newly launched Sublocade treatment.
Read moreSector movers: Political uncertainty boosts defensives
6th Feb 2017 14:12
(ShareCast News) - Defensives outperformed at the start of the week as a wave of risk aversion linked to heightened political worries broke over global equity markets. That followed a rally by French president hopeful Marine Le Pen at the weekend in which she laid out her plans for a referendum o
Read moreFTSE 250 movers: Beazley comes out on top; miners fall
3rd Feb 2017 14:38
(ShareCast News) - The FTSE 250 index rose 0.89% to 18,421.49 at 1609 GMT on Friday. Insurer Beazley was in the green as it reported a 3% jump in full-year profit as premiums written increased and the company lifted its dividend. In the year to the end of December, pre-tax profit rose to $293.2m fro
Read moreMonday broker round-up
7th Nov 2016 11:39
(ShareCast News) - Acacia Mining: JP Morgan keeps at overweight with a target price of 620p. Indivior: Jefferies stays at buy, 450p target. Centrica: Berenberg reiterates buy with a 240p target. South 32: Deutsche Bank reiterates hold with a 122p target. Glencore: JP Morgan keeps at neutral with
Read moreIndivior hikes profit guidance, records first antitrust charge
2nd Nov 2016 15:04
(ShareCast News) - Indivior increased its full year revenue guidance to reflect faster growth in the USA and also recorded a $220m charge relating to antitrust litigation currently going through the courts The FTSE 250 anti-addiction drug group reported revenues of $268m for the third quarter to 30
Read moreIndivior rebuffs complaint from 35 US states
27th Sep 2016 08:39
(ShareCast News) - Pharmaceutical company Indivior once again rebuffed legal claims laid against it on Tuesday, after a number of states in the US filed a joint civil complaint over its conduct with the Suboxone product. The FTSE 250 firm had initially warned the market of the impending complaint, f
Read moreIndivior facing lawsuit from 35 states and DC
23rd Sep 2016 07:11
(ShareCast News) - Indivior updated the market on the Federal Trade Commission investigation and class action litigation being filed against it on Friday. On 29 July, the FTSE 250 company indicated that the FTC was seeking court action over the drug Suboxone, having investigated whether Indivior and
Read more